NOAEL Studies
Cosmetic Ingredient
3-Benzylidene Camphor NOAEL Studies
INCI: 3-BENZYLIDENE CAMPHOR
CAS: 15087-24-8
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
SCCS Opinion 12 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.21 | mg/kg bw | rat | oral | - | NOAEL study | p.24 |
| SCCS Opinion | NOAEL | =2 | % | rat | - | - | NOAEL study | p.24 |
| SCCS Opinion | NOAEL | =7.5 | mg/kg bw/d | rat | oral | - | NOAEL study | p.24 |
| SCCS Opinion | NOAEL | =15 | mg/kg bw/day | mouse | oral | 56 day | NOAEL study | p.15 |
| SCCS Opinion | NOAEL | =15 | mg/kg bw/d | rat | oral | - | NOAEL study | p.24 |
| SCCS Opinion | NOAEL | =18 | - | human | dermal | - | NOAEL study | p.5 |
| SCCS Opinion | NOAEL | =20 | mg/kg bw/day | rat | oral | 6 week | reproductive toxicity | p.25 |
| SCCS Opinion | NOAEL | =25 | mg/kg bw/d | guinea pig | oral | 15 days | NOAEL study | p.12 |
| SCCS Opinion | NOAEL | =40 | mg/kg bw/day | - | - | 38 weeks | genotoxicity | p.13 |
| SCCS Opinion | NOAEL | =50 | mg/kg bw/day | - | - | 45 d | NOAEL study | p.15 |
| SCCS Opinion | NOAEL | =50 | % | rat | oral | - | NOAEL study | p.24 |
| SCCS Opinion | NOAEL | =250 | mg/kg bw/d | rat | oral | sub-chronic | repeated dose toxicity | p.11 |
Regulatory source 14 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | =0.21 | mg/kg bw | rat | oral | - | - | p.24 |
| Regulatory source | - | =2 | % | rat | - | - | - | p.24 |
| Regulatory source | - | 2 | % | rat | oral | 4 week | - | p.26 |
| Regulatory source | - | =7.5 | mg/kg bw/d | rat | oral | - | - | p.24 |
| Regulatory source | - | 15 | mg/kg bw/day | mouse | oral | 56 day | - | p.15 |
| Regulatory source | - | =15 | mg/kg bw/d | rat | oral | - | - | p.24 |
| Regulatory source | - | 18 | - | human | dermal | - | - | p.5 |
| Regulatory source | - | 25 | mg/kg bw/d | guinea pig | oral | 15 days | - | p.12 |
| Regulatory source | - | 50 | mg/kg bw/day | - | - | 45 d | - | p.15 |
| Regulatory source | - | 50 | % | rat | oral | - | - | p.24 |
| Regulatory source | genotoxicity | 40 | mg/kg bw/day | - | - | 38 weeks | genotoxicity | p.13 |
| Regulatory source | repeated dose toxicity | 250 | mg/kg bw/d | rat | oral | sub-chronic | repeated dose toxicity | p.11 |
| Regulatory source | reproductive toxicity | 15 | mg/kg bw/day | rat | - | - | reproductive toxicity | p.25 |
| Regulatory source | reproductive toxicity | 20 | mg/kg bw/day | rat | oral | 6 week | reproductive toxicity | p.25 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 2F60H204CM | UNII | - | - | - | chemical | - |